AIRMAX™ Nasal Device Debuts at International ENT Show in Vancouver
WARREN – October 29, 2013 - McKeon Products, Inc. officially unveiled the revolutionary Airmax™ Nasal Device to Ear, Nose and Throat Doctors from around the world at the AAO-HNSF Annual Meeting and OTO Expo in Vancouver this month. Debuting in the international spotlight was significant for McKeon Products, Inc., as it currently markets products in over 71 countries.
The Airmax™ Nasal Device was favorably received by the doctors, as many have been seeking a device for their patients that outperforms nasal strips. The Airmax™ Nasal Device is different from other nasal devices on the market, as it expands the narrowest parts of the nasal channel allowing maximum airflow. Multiple clinical studies have proven its effectiveness in improving airflow, reducing snoring, and reducing mild sleep apnea. Additionally, the results of a recent study show that consumers preferred the Airmax™ over other nasal device alternatives, including nasal strips.
The Airmax™ Nasal Device is a clinically proven endonasal (inside the nasal passage) medical device that increases airflow through the nose, providing a simple and effective solution for individuals who have difficulties breathing while sleeping or as a result of colds and allergies. Pamela from Sterling Heights, Michigan has this to say about the Airmax™ Nasal Device, “From the very first night of using Airmax™, my breathing improved. I would love it if my airways could stay open all day like they do at night. Thanks, Airmax™!”
The Airmax™ Nasal Device is important in helping consumers address nasal breathing difficulties and sleep challenges. The negative effects of habitual snoring can put people at risk for serious health problems, including obstructive sleep apnea, which can also put undue strain on the heart. In general, lack of quality sleep can lead to drowsiness during the day and can interfere with quality of life.
McKeon Products, Inc.